| 1 |
33691270 | Molecular modeling study of the testosterone metabolizing enzyme UDP-glucuronosyltransferase 2B17. | 2021 Apr 15 |
2 |
| 2 |
34361561 | Potential Assessment of UGT2B17 Inhibition by Salicylic Acid in Human Supersomes In Vitro. | 2021 Jul 21 |
1 |
| 3 |
34541032 | Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer. | 2021 |
1 |
| 4 |
31376206 | Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion. | 2019 Sep |
2 |
| 5 |
29659189 | The effect of tea consumption on the steroid profile. | 2018 Sep |
1 |
| 6 |
30086285 | Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism. | 2018 Oct |
3 |
| 7 |
30616396 | UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data. | 2018 Sep - Dec |
1 |
| 8 |
27706926 | Discordant genotyping results using DNA isolated from anti-doping control urine samples. | 2017 Jul |
2 |
| 9 |
28404691 | Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer Cells. | 2017 Jun |
1 |
| 10 |
26677027 | Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports. | 2016 Jan |
1 |
| 11 |
25794161 | Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males. | 2015 May |
6 |
| 12 |
26163549 | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 2015 Sep |
1 |
| 13 |
26198073 | Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism. | 2015 Nov-Dec |
1 |
| 14 |
24782830 | The impact of genetics and hormonal contraceptives on the steroid profile in female athletes. | 2014 |
2 |
| 15 |
24879639 | Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver. | 2014 Oct 15 |
1 |
| 16 |
22887913 | UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse. | 2013 Mar |
3 |
| 17 |
23720652 | Non-steroidal anti-inflammatory drugs do not influence the urinary testosterone/epitestosterone glucuronide ratio. | 2013 |
1 |
| 18 |
22429924 | Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation. | 2012 May |
5 |
| 19 |
22958586 | Red wine and component flavonoids inhibit UGT2B17 in vitro. | 2012 Sep 7 |
2 |
| 20 |
21849521 | Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men. | 2011 Nov |
1 |
| 21 |
21884791 | Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids. | 2011 Nov |
2 |
| 22 |
21928278 | Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios. | 2011 Oct |
2 |
| 23 |
20628005 | A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide. | 2010 Oct |
1 |
| 24 |
19022937 | UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. | 2009 Feb |
4 |
| 25 |
19224506 | [Testosterone metabolism and doping test results]. | 2009 Jan-Feb |
1 |
| 26 |
19643121 | Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation. | 2009 Nov |
3 |
| 27 |
17387331 | Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. | 2008 Apr |
1 |
| 28 |
18992858 | Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. | 2008 Dec |
2 |
| 29 |
17151189 | The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7. | 2007 Mar |
1 |
| 30 |
16332934 | Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. | 2006 Feb |
3 |
| 31 |
11159850 | Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. | 2001 Feb |
2 |
| 32 |
8798464 | Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. | 1996 Sep 13 |
1 |